Division of Health Policy and Management

Health policy and management focuses on equity in access to health services as this is indispensable for maintaining and improving the health of the population. Since policy can only be understood within each country’s history, this course will focus on Japan. However, the course will be based on global concepts and trends so that the contents could be adapted to other countries. In particular, Japan would be able to provide a model for the super aged society.

Courses Offered by Division Faculty

Health Policy and Management

The purpose of this course is to understand how health policy historically has unfolded by focusing on the development of healthcare providers and payment system in Japan. Long-term care and end-of-life care will be covered as they are essential for understanding the needs of a rapidly aging society. The financing aspects will be taught in the Health Economics course. (Required Course)

Health Economics

The purpose of this course is to understand the key aspects determining healthcare: egalitarian principle, unpredictability of need, information asymmetry between physician and patient, and uncertainty of outcome, using Japan as an example. This course will be from the perspective of citizens and patients. Long-term care insurance (LTCI) will be studied as it would illustrate the uniqueness of healthcare, and also show how society copes with the aging society. Lastly, pharmaco-economic analysis will be explained using concrete examples. Note that the providers’ perspective will be covered in the Health Policy and Management course. (Elective Course)

Hospital Administration

To understand the characteristics of hospital organizations, the rules and regulations that they must comply, and learn how to use management resources for setting and achieving management goals. (Elective Course)

Pharmaco-epidemiology and Pharmaco-economics

This course will cover the issues and techniques in observational studies for the assessment of drug usage, safety and efficacy. The basis for cost-effectiveness in medical technology (pharmaco-epidemiology evaluations) and recent information about how it can be applied will also be examined. (Elective Course)